Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc.

ARWR

Market Cap$2.22B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Arrowhead Pharmaceuticals Inc.Arrowhead Pharmaceuticals Inc.-14.6--21%40.1
$-3.99

Current Fair Value

125.3% downside

Overvalued by 125.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.22 Billion
Enterprise Value$2.08 Billion
Dividend Yield$0 (0%)
Earnings per Share$-5
Beta0.95
Outstanding Shares133,363,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-14.63
PEG3.72
Price to Sales3.95
Price to Book Ratio3.16
Enterprise Value to Revenue3.81
Enterprise Value to EBIT-22.8
Enterprise Value to Net Income-15
Total Debt to Enterprise0.02
Debt to Equity0.06

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Arrowhead Pharmaceuticals Inc.

CEO: Christopher Anzalone